isis pharmaceuticals inc
(ISIS:Consolidated Issue Listed on NASDAQ Global Select )
B. Lynne Parshall Esq., J.D.
Chief Operating Officer, Corporate Secretary, Director and Member of Agenda Committee, Isis Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 47 board members in 3 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2013
Ms. B. Lynne Parshall, Esq., J.D. has been the Chief Operating Officer of Isis Pharmaceuticals, Inc. since December 2007 and serves as its Corporate Secretary. Ms. Parshall served as Secretary at Isis Pharmaceuticals, Inc. since November 1991. Ms. Parshall served as an Executive Vice President since December 1995, Chief Financial Officer from June 1994 to January 2013, Senior Vice President from February 1993 to December 1995 and Vice President from November 1991 to ...
2855 Gazelle CourtPhone: 760-931-9200
Carlsbad, California 92010
Board Members Memberships*
Chief Operating Officer, Corporate Secretary, Director and Member of Agenda Committee
Director, Chairman of Audit Committee and Member of Nominating & Governance Committee
Former Director and Chairman of Audit Committee
Director and Member of Audit Committee
Director, Member of Audit Committee and Member of Nominating & Governance Committee
Stanford University Law school
|Ron Cohen M.D.||Founder, Chief Executive Officer, President and Director|
Acorda Therapeutics, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|Uli Hacksell Ph.D.||Chief Executive Officer, President and Director|
ACADIA Pharmaceuticals Inc.
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|